The pleural space is a thin cavity between the two layers of the pleura, which is a membrane that lines the chest wall and lungs. It is filled with a small amount of fluid that helps lubricate the space and enable the lungs to move easily within the chest cavity. When this space becomes filled with an abnormal amount of fluid, it is known as pleural effusion. This condition can be caused by a variety of factors, including infection, tumors, heart failure, and autoimmune diseases. In this article, we will explore the various causes of pleural effusion and how they can be diagnosed and treated.
Pleural effusion is an accumulation of fluid in the pleural space, which can cause discomfort and breathing difficulty. This fluid can be either transudate, which is a non-inflammatory fluid, or exudate, which is an inflammatory fluid. The cause of the effusion can be determined by analyzing the fluid. Common causes of pleural effusion include infection, heart failure, malignancy, and autoimmune diseases.
Infection is one of the most common causes of pleural effusion, particularly in children. The most common causes of infection-related pleural effusion are pneumonia, tuberculosis, and other respiratory viruses. In some cases, the infection can spread to the pleural space and cause an accumulation of fluid.
Another common cause of pleural effusion is heart failure. When the heart is unable to pump enough blood around the body, it can cause fluid to back up in the lungs and pleural space. This can lead to an accumulation of fluid in the pleural space, resulting in pleural effusion.
Malignancy, or cancer, can also cause pleural effusion. Cancer cells can spread to the pleural space and cause an accumulation of fluid. This can be seen in lung cancer, mesothelioma, and other types of cancer.
Autoimmune diseases, such as rheumatoid arthritis, lupus, and scleroderma, can also cause pleural effusion. In these cases, the body’s immune system attacks the pleural space, resulting in an accumulation of fluid.
Pleural effusion is typically diagnosed through imaging tests, such as chest X-rays or CT scans. Once the effusion has been confirmed, the cause must be determined. This can be done through a variety of tests, including a pleural fluid analysis, a pleural biopsy, or a thoracentesis. Once the cause of the effusion has been determined, treatment can begin. Treatment will vary depending on the cause of the effusion, but may include antibiotics for infection, diuretics for heart failure, chemotherapy for cancer, or immunosuppressive drugs for autoimmune diseases.
Pleural effusion is an accumulation of fluid in the pleural space. It can be caused by a variety of factors, including infection, heart failure, malignancy, and autoimmune diseases. Diagnosis is typically done through imaging tests, such as chest X-rays or CT scans, and treatment will vary depending on the cause. With proper diagnosis and treatment, pleural effusion can be managed and the patient’s quality of life can be improved.
1.
findings from the measurement of disability weights in China with an emphasis on the impact of disease burden.
2.
Maintenance Rituximab Improves Survival in Elderly MRD-Negative MCL Patients.
3.
Understudied mental health challenges among caregivers of cancer patients: A call for targeted support
4.
A Texas study found that the majority of pancreatic cancer patients do not receive life-saving surgery.
5.
According to a study, taking part in a clinical trial for cancer may not actually increase survival.
1.
A New Hope: How Procarbazine is Revolutionizing Cancer Treatment
2.
Oncology Treatment: Innovations, Education, and Clinical Practice Insights
3.
Hypogammaglobulinemia: A Comprehensive Guide for Patients and Caregivers
4.
Unleashing the Power of Immune Triads: A Novel Approach to Cancer Immunotherapy
5.
The Importance of Early Detection in Angiosarcoma: A Story of Survival
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
2.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
3.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
4.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
5.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation